Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2014
05/07/2014CN101993432B 基于咔唑的唑类查尔酮衍生物及其制备方法 Carbazole-based azole chalcone derivative and preparation method
05/07/2014CN101925586B 杂环化合物 Heterocyclic Compounds
05/07/2014CN101910157B 吲哚化合物和治疗内脏痛的方法 And methods for treating visceral pain indole compound
05/07/2014CN101679308B Hedgehog途径抑制剂 Hedgehog pathway inhibitor
05/07/2014CN101528731B 具有AuroraA选择性抑制作用的氨基吡啶衍生物 Selective inhibition has AuroraA aminopyridine derivative
05/07/2014CN101516850B 适用作e1活化酶抑制剂的杂芳基化合物 Activating enzyme inhibitors suitable for e1 heteroaryl compound
05/06/2014US8716493 Multicyclic compounds and the use thereof
05/06/2014US8716492 Five-membered heterocycles useful as serine protease inhibitors
05/06/2014US8716491 Benzimidazolium dyes and their use as fluorescent chemosensors
05/06/2014US8716477 Crystalline forms of bosentan salts and processes for their preparation
05/06/2014US8716475 2-aminopyrimidine modulators of the histamine H4 receptor
05/06/2014US8716473 Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase
05/06/2014US8716472 Tripodal cyclohexane derivatives and their use as carbohydrate receptors
05/06/2014US8716315 Analogs of thalidomide as potential angiogenesis inhibitors
05/06/2014US8716290 Heterocyclic compounds and their uses
05/06/2014US8716282 Imidazo[1,2-b]pyridazine derivatives and their use as PDE10 inhibitors
05/06/2014US8716277 Substituted imidazole compounds useful as positive allosteric modulators of mGlu5 receptor activity
05/06/2014CA2768290C R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for thepreparation thereof and pharmaceutical composition comprising the same for antimicrobial
05/06/2014CA2742539C Disubstituted phthalazine hedgehog pathway antagonists
05/06/2014CA2574040C Iap binding compounds
05/01/2014WO2014066506A2 Compositions and methods for jamm protein inhibition
05/01/2014WO2014066204A1 Combination
05/01/2014WO2014065860A1 Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions
05/01/2014WO2014064219A1 1 h-indole-3-carboxamide derivatives and use thereof as p2y12 antagonists
05/01/2014WO2014064149A1 4-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors
05/01/2014WO2014064134A1 3,4-disubstituted 1 h-pyrazole and 4,5-disubstituted thiazole inhibitors of syk
05/01/2014WO2014064129A1 Pyrazole compounds for controlling invertebrate pests
05/01/2014WO2014064064A1 Iminoxytriazines as radical generators
05/01/2014WO2014064038A1 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine d3 receptor
05/01/2014WO2014063942A1 Substituted pesticidal pyrazole compounds
05/01/2014WO2014063929A1 Substituted pesticidal pyrazole compounds
05/01/2014WO2014063752A1 Process for making crystalline form alpha of eletriptan hydrobromide
05/01/2014WO2014063642A1 Substituted pyrimidine compound and uses thereof
05/01/2014WO2014063631A1 Tyrosine kinase irreversible inhibitor and preparation method and applications thereof
05/01/2014US20140121376 Tricyclic spacer systems for nonlinear optical devices
05/01/2014US20140121195 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists
04/2014
04/30/2014EP2725025A1 Derivatives of 1H-indole-3-carboxamide and their use as P2Y12 antagonists
04/30/2014EP2725024A1 Azole heterocyclic compound, preparation method, pharmaceutical composition and use
04/30/2014EP2725015A1 Uracil or thymine derivative for treating hepatitis c
04/30/2014EP2723731A1 Metalloenzyme inhibitor compounds
04/30/2014EP2723729A1 Pesticidal compositions and processes related thereto
04/30/2014EP2723721A1 Polyphenylene host compounds
04/30/2014EP2723717A2 Trpm8 antagonists and their use in treatments
04/30/2014CN103764786A Novel organic electroluminescent compounds and an organic electroluminescent device using the same
04/30/2014CN103764645A Microbiocidal heterocycles
04/30/2014CN103764642A Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants
04/30/2014CN103764630A Sweet flavor modifier
04/30/2014CN103755687A Hydrochloric tandospirone crystal form I and preparation method of crystal form I
04/30/2014CN103755652A Sulfonamide compound and application thereof
04/30/2014CN103755595A Hydroxamic acid derivative and application thereof
04/30/2014CN103755587A Derivatives of 4-polyfluoroalkyl-2,4-disubstituted pyrrole and preparation method thereof
04/30/2014CN102558157B Ethoxyl-triazole compound or amonoethyl-triazole compound and preparation method and application thereof
04/30/2014CN102428079B Imidazolidine-2,4-dione derivatives and use thereof as a medicament
04/30/2014CN102112467B Pyrimidine derivative as kinase inhibitors
04/30/2014CN102015690B Catalyzed carbonylation in the synthesis of angiotensin II antagonists
04/30/2014CN101633655B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
04/29/2014US8710261 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
04/29/2014US8710229 Hepatitis C virus inhibitors
04/29/2014US8710198 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof
04/29/2014US8710174 Triazine ring-containing polymer and film-forming composition comprising same
04/29/2014US8710086 Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof
04/29/2014US8710046 5-HT3 receptor modulators, methods of making, and use thereof
04/29/2014US8710038 Pyrazole kinase modulators and methods of use
04/29/2014CA2753552C N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
04/29/2014CA2637631C Pyrimidine compounds and uses thereof
04/29/2014CA2573976C Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
04/29/2014CA2570873C Pyrimidine urea derivatives as kinase inhibitors
04/29/2014CA2554809C Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase
04/29/2014CA2524009C Use of effectors of glutaminyl and glutamate cyclases
04/24/2014WO2014063068A1 Inhibitors of cyclin-dependent kinase 7 (cdk7)
04/24/2014WO2014061991A1 Novel organic electroluminescent compounds and organic electroluminescent device containing the same
04/24/2014WO2014061961A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same
04/24/2014WO2014060900A1 Process for the preparation of voriconazole and analogues thereof
04/24/2014WO2014060770A1 Bicyclic heterocycle compounds and their uses in therapy
04/24/2014WO2014060768A1 Bicyclic heterocycle compounds and their uses in therapy
04/24/2014WO2014060767A1 Bicyclic heterocycle compounds and their uses in therapy
04/24/2014WO2014060411A1 Rsv antiviral compounds
04/24/2014WO2014060386A1 Indol-amide compounds as beta-amyloid inhbitors
04/24/2014WO2014060381A1 Heterocyclic compounds as pesticides
04/24/2014US20140114067 Benzimidazole derivatives as mitochondrial function modulators
04/24/2014US20140114064 P38 map kinase inhibitors
04/24/2014US20140113945 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents for Liver Toxicity
04/24/2014US20140113938 Pyrrole Inhibitors of S-Nitrosoglutathione Reductase
04/24/2014US20140113917 Pyrazole compounds as crth2 antagonists
04/24/2014US20140113890 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
04/24/2014US20140113005 Compounds useful as inhibitors of atr kinase
04/23/2014EP2722329A1 Indol-amide compounds as beta-amyloid inhbitors
04/23/2014EP2722046A1 2-((R)-2-methylpyrrolidin-2-YL)-1H-benzimidazole-4-carboxamide crystalline form 1
04/23/2014EP2721031A2 Bromodomain inhibitors and uses thereof
04/23/2014EP2721014A2 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
04/23/2014EP2721011A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
04/23/2014CN103748089A Pesticidal compositions and processes related thereto
04/23/2014CN103748076A Rorgammat inhibitors
04/23/2014CN103740359A Thermal activation delayed fluorescence material, synthesis method thereof and OLED (Organic Light Emitting Diode) device using thermal activation delayed fluorescence material
04/23/2014CN103739595A Compounds and compositions as protein kinase inhibitors
04/23/2014CN103739594A Schiff base derivatives containing pyrazine ring and triazole structure and preparation method of the derivatives
04/23/2014CN103739555A Chemical sensor for fluorescence quenching detection of nitro-aromatic explosives and preparation method thereof
04/23/2014CN103739550A 2, 3-dimethyl-6-urea-2H-indazole compound and preparation method and application thereof
04/23/2014CN102395577B Diazepinedione derivative
04/23/2014CN101977908B (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 626